NCT04009668 2024-10-30
Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
University of Michigan
Phase 2 Completed
Clinical Trials
4 trialsNCT03180957 2024-06-28
RIDD
University of Oxford
Phase 2 Completed
NCT00311246 2020-08-25
Trial of Adalimumab in Progressive Sarcoidosis
University of Chicago
Phase 2 Terminated
NCT02456363 2015-05-28
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Chung Shan Medical University
Phase 2 Unknown